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Most determinations of tissue plasminogen activator (TPA)
activity have been done with qualitative or semiquantitative
variations of the fibrin-overlay technique [l—4J, However, to
meaningfully compare renal TPA activities between animal
species or in same kidneys under different conditions, a quanti-:
tative and sensitive assay is required. We are reporting here the
development of such an assay based on a two-step reaction: (1)
activation of plasminogen (Pig) to plasmin by renal TPA, and (2)
quantitation of plasmin by using S2251, a chromogenic sub-
strate highly specific for this enzyme.
Methods. The chromogenic substrate S2251 (H-D-Val-Leu-
Lys-pNa) was purchased from Kabi AB (Stockholm, Sweden).
Human lysine-plasminogen iLys-PIg; 1 mg of protein = 30 CTA
(Committee on Thromboiytic Agents) UI and streptokinase
(SK) were generous gifts of the Choay Laboratory (Paris,
France) and Hoechst Co. (Somerville, New Jersey), respective-
ly. All chemicals were reagent grade.
Kidneys of male Wistar rats were removed through a midline
abdominal incision under light ether anesthesia. Kidneys were
not flushed after their removal, because there is no difference in
fibrinolytic activity between flushed and unflushed kidneys [51.
The cortex and medulla were separated and snap-frozen in
aluminum foil vessels containing OCT compound immersed in a
mixture of dry ice and acetone. The blocks of tissue were stored
at —70° C until cryostat-cut sections were prepared. The sec-
tions were also stored at —70° C (usually not longer than 2
weeks) until the assay.
Whole rat-kidney homogenate, 50 mg of wet tissue per ml of
buffer, was prepared in phosphate-buffered saline (PBS), pH
7.4. The tissue was frozen, thawed, minced, sonicated, and
centrifuged at 27,000 g for 30 mm at 4° C. The supernatant was
stored in aliquots at —70° C and used as a positive control for
the TPA assay.
TPA assay: tissue sections. Each tissue section (on a glass
slide) is washed three times in 3 mm with an ice-cold buffer
solution of 50 mM Tris and 150 m sodium chloride, pH 7.4
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(buffer A). After washing, the tissue is transferred into a
prewarmed (37° C) glass test tube containing 7.5 p.g (0.225 CTA
units) of Lys-PIg in 50 j.l of buffer A. After timed incubation at
37° C in a water-bath shaker, 50 I of buffer A is added and
mixed. A 50-ui aliquot of this solution is then transferred to a
prewarmed cuvette containing (1) 50 g (final concentration of
0.6 mM, that is: twice the Km) of S2251 dissolved in 50 p.I of
buffer A and (2) L-lysine (final concentration 110 mM) dissolved
in 50 ii.l of 50 mi Tris buffer, pH 7.4, which inhibits the TPA
and prevents the autodegradation of plasmin. The cuvettes are
incubated for exactly 30 mm at 37° C. The reaction is stopped
with 0.55 ml of 10% acetic acid and the absorbance at 405 nm is
read spectrophotometrically. The blank consisted of Lys-Pig
incubated without the tissue to determine the spontaneous
conversion of Plg into plasmin. Originally tissue was incubated
also in buffer A without Lys-Plg to detect the presence of any
S225 1-cleaving enzymes other than plasmin. As no activity was
detected, this blank was omitted eventually. With each assay
the positive control comprised 50-1.d aliquots of a whole rat
kidney homogenate with a known TPA activity. Prior to its use
as a positive control, TPA activity in the aliquots of this
homogenate, stored at —70° C, was assayed repeatedly as
described below, to determine the intra- and interassay coeffi-
cient of variation. All samples, blanks, and controls were
assayed in triplicate.
The standard curve is prepared by using known quantities of
Lys-PIg, fully activated by incubation with SK (2000 U SK/p.g
of Plg) for 10 mm at 37° C. Higher SK concentrations or longer
incubation resulted in a decreased activity (data now shown).
The results are expressed in nanograms of activated Plg/time/
area of tissue. Tissue area was measured prior to the assay by
placing the glass slides with the mounted tissue sections over
graph paper (10 x 10 to the centimeter), and the number of
square millimeters overlapped by the section was counted using
a magnifying glass. The linear range of the standard curve
extends from 10 ng (3 x l0 CTA U) to 300 ng of activated Pig
(Fig. 1). SK by itself does not have amidolytic activity toward
S2251.
TPA assay: kidney homogenate. The kidney homogenate is
diluted in buffer A, and 50-pA aliquots are incubated with 7.5 p.g
of Lys-Plg in 50 p.1 of buffer A for 60 mm at 37° C. A 50-pA
aliquot of this solution is transferred to a prewarmed cuvette
containing 50 p.1 of L-lysine and 50 p.l of S225 1, as described
above, and incubated for 30 mm at 37° C. The reaction is
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stopped with 0.55 ml of 10% acetic acid. Blanks were similar to
those described above. Results are expressed as nanograms of
activated Pig/hr/SO l of homogenate.
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Results. A linear relationship was found between the activity
of the tissue-activated Lys-PIg and the length of incubation up
to 2 hr (Fig. 2). A linear relationship was also observed between
the activation of Lys-PIg and the area of 20-p.m-thick sections
(Fig. 3). When the thickness of the section was changed but
constant area was maintained (13.5 mm2/section), the linear
relationship extended up to 30-p.m thickness or a tissue volume
of 0.4 mm3 (Fig. 4). There was no correlation between the
number of glomeruli and TPA activity (r =
—0.22, N = 20
sections; data not shown). TPA activity was similar in sections
with and without small intralobular blood vessels. Absorbance
showed a linear correlation with kidney-homogenate dilution
from 1:20 to 1:40 (Fig. 5).
In the homogenate assay, 50 p.1 (2.5 mg of tissue) activated
4.164 p.g of PlgIhr. The intraassay and interassay coefficients of
variation (CV) were 5.7% and 9.1%, respectively.
Renal cortical (20-p.m) sections of varied area (5 to 12 mm2)
obtained from 22 rats, 2 weeks to 18 months old, activated 101
30 ng (X SD) of Pig/b mm2/hr. The activity was standarized
to 10 mm2 according to the slope of the linear regression
between the area and the absorbance. The intraassay CV was
9.6%. There was no correlation between cortical TPA activity
and age. Medullary TPA activity measured in 17 sections from
two rats was equivalent to activation of 225 28 ng of Plg/10
mm2/hr whereas cortical activity in 20 sections from the same
rats was equivalent to 115 23 ng/l0 mm2/hr (P < 0.001).
Incubation of renal cortical sections in the presence of 0.5%
Triton X-100 caused a three- to fourfold increase in TPA
activity.
Discussion. Most of the direct quantitative assays of plasmin-
ogen activator (PA), employing 25I-labeled or unlabeled fibrin,
casein, or synthetic substrates, have been used primarily in
studies of cellular cultures [6—i 1]. Few quantitative studies of
renal TPA have used fibrin as a substrate [12, 13]. Although
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Fig. 1. Standard curve prepared using Lys-plasminogen fully activated
by Streptokinase (2000 U of streptokinase per 1 p.g of lys-plasminogen
incubated for 10 mm at 37° C), and the plasmin specific chromogenic
substrate S2251 at final concentration of 0.6 m.
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Fig. 3. Linear relationship between tissue plasminogen activator and
the area of 20-p. thick tissue sections incubated with 7.5 p.g Lys-
plasminogen for 1 hr at 37° C.
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Fig. 2. Linear relationship between tissue plasminogen activator and
incubation time of the tissue with 7.5 p.g Lys-plasminogen at 37° C.
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Fig. 4. Relationship between tissue plasminogen activator and the
thickness of tissue sections incubated with 7.5 p.g Lys-plasmmnogen for
1 hr at 37° C.
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these techniques are sensitive, utilization of fibrin poses several
problems. Fibrin is insoluble, and the nature and number of
cleavages required for plasmin to release an '2l-labeied frag-
ment are uncertain. Also, the exact dependence of the reaction
rate upon the state of the fibrin is unknown. Considerable
differences have been observed under apparently identical
conditions due to isotope decay and changes in fibrinogen
clottability upon storage. The kinetics of the reaction are
nonlinear and complex, making quantitative analysis difficult.
In addition, use of '251-labeled fibrin includes the inconvenience
of handling radioactive isotopes. Recently, a direct assay of
cellular PA with another chromogenic substrate (S2322; Kabi
AB) was reported [141, but the specificity of this substrate has
not been documented. Furthermore, the amidolytic activity of
TPA does not necessarily parallel its fibrinolytic activity [151.
The use of S2251 in one step [6, 7] or multistep [111 assays has
been reported previously. Drapier et al [6] described a one-step
assay in which the TPA, Pig, and S2251 are reacted simulta-
neously. The disadvantages of this method are the nonlinear
formation of the chromogenic product requiring a binominal
analysis for the calculation of the results; the sensitivity of this
assay allows detection of not less than 0.003 CTA U of
urokinase; and the end-point method cannot be used.
To avoid the nonlinearity and improve the sensitivity, Searls
[11] developed a multistep technique which includes diazotiza-
tion and coupling procedures. Though the sensitivity increased,
allowing detection of as low as 50 ng of PIg, the assay is
relatively cumbersome. To reduce the number of steps and to
increase the sensitivity, we used Lys-PIg which has a high
catalytic constant [16], thus eliminating the need for the epsilon
aminocaproic acid, diazotization, and coupling and still achiev-
ing a sensitivity which allows for the detection of as low as 10 ng
(0.0003 CTA U) of activated PIg. Because the for known PA
is on the order of 4 x 105M [17], we employed a fixed
concentration of Lys-PIg (150 .g/ml) which is sufficiently high
to allow a linear reaction. Use of Lys-PIg should also prevent
the variability, as different preparations of PIg have various
concentrations of Lys-Plg and glutamic-PIg. Furthermore, this
is the first report describing an assay of TPA in tissue sections
using S2251.
The assay of kidney TPA presented here has several advan-
tages. The sections can be obtained from any desired location
and can be pretreated easily with a variety of agents. The two-
step assay provides flexibility, allowing study of the effect of
various conditions and agents on the level of TPA activity. In
addition, not only the surface-bound or leached TPA, but also
the intracellular, membrane-bound TPA can be measured by
using membrane-disrupting agents such as Triton X-lOO or
deoxycholate [181. Tissues that contain very little TPA can be
incubated longer, or a larger tissue volume can be used.
The use of human Plg as a substrate for TPA of other species
should pose no problems as there is no difference in the results
of fibrinolytic assays with homologous versus heterologous
substrates [19]. The sixfold dilution of TPA and Lys-Pig and the
addition of L-lysine during the second step of the assay serve to
inhibit TPA activity [20], allowing for a linear reaction between
activated Plg and S225 1. Addition of L-lysine also inhibits the
autodegradation of plasmin [9].
Our findings of a significantly higher TPA activity in the renal
medulla rather than in the cortex is similar to results described
by other authors [5, 13, 211. Lack of correlation between the
number of glomeruli and the activator is probably related to the
observation that glomeruli have relatively very little fibrinolytic
activity [5, 13, 21].
The availability of a quantitative, sensitive assay of renal
TPA should help to elucidate this enzyme's role in a variety of
physiologic and pathologic conditions of the kidneys.
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